A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases

NCT06978647 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus (SLE)
Systemic Sclerosis (SSc)
Inflammatory Myopathy
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Antiphospholipid Syndrome (APS)
Rheumatoid Arthritis (RA)
IgG4-Related Diseases
Sjogren's Syndrome

Interventions

DRUG: YTS109 cell

Sponsor

China Immunotech (Beijing) Biotechnology Co., Ltd.

Collaborators

[object Object]